286TiPPhase II randomized trial of neoadjuvant trastuzumab and pertuzumab (TP) with either palbociclib + letrozole (Pal+L) or paclitaxel (Pac) for elderly patients with estrogen receptor & HER2 positive (ER+/HER2+) breast cancer (BC) (International Breast Cancer Study Group IBCSG 55-17, TOUCH)
Biganzoli, L, Brain, E, Malorni, L, Risi, E, Regan, M MVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz240.109
Date:
October, 2019
File:
PDF, 82 KB
2019